Eckert & Ziegler Isotope
Website to be confirmed.
About Eckert & Ziegler Isotope
Eckert & Ziegler Isotope operates in the Isotope Supply space and is among the firms Bracken expects to track at SNMMI 2026.
Longer summary placeholder. Replace once Bracken finalizes the exhibitor profile copy.
What we're seeing
- FierceBiotech · 2026-07-22Eckert Ziegler Isotope appoints new Chief Medical Officer ahead of pivotal trialIndustry observers expect more activity of this kind in the run-up to SNMMI 2026.
- BioPharma Reporter · 2026-08-17Eckert Ziegler Isotope signs supply agreement to support late-stage trialsIndustry observers expect more activity of this kind in the run-up to SNMMI 2026.
- Reuters Health · 2026-05-08Eckert Ziegler Isotope expands cyclotron capacity to meet Lu-177 demandThe announcement comes amid tightening Mo-99 and Lu-177 supply.
- Endpoints News · 2026-02-03Eckert Ziegler Isotope announces Phase II readout for lead theranostic candidateIndustry observers expect more activity of this kind in the run-up to SNMMI 2026.
Mocked while we wire the Exa integration. Headlines are illustrative.
What we expect to see at the booth
Booth talking points, demos, and announcements to watch for. Bracken analyst note coming.
A short Bracken POV will go here, drawing on our experience across this part of the radiopharma value chain. Specific commentary to be filled in by the team.
Editorial shown for exhibitors in Bracken's wheelhouse: radiopharma developers, isotope supply, CDMO/CMO, cyclotron, and imaging equipment.
Companies you may also want to visit.
ABX advanced biochemical compounds
Profile under construction. Check back closer to SNMMI 2026 for Bracken's read on ABX advanced biochemical compounds.
View profile →BWXT Medical Ltd.
Profile under construction. Check back closer to SNMMI 2026 for Bracken's read on BWXT Medical Ltd..
View profile →Eckert & Ziegler Medical
Profile under construction. Check back closer to SNMMI 2026 for Bracken's read on Eckert & Ziegler Medical.
View profile →